Companies
Merck KGaA
Science and technology company — MilliporeSigma / Mobius single-use bioprocessing, Millipore filtration, and BioReliance contract testing for biopharma.
- Country
- Germany
- Revenue
- €22B
- Employees
- ~63,000 emp
GMP EU
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
| cleanroom-facilities | ✓ | ✓ | ✓ |
| consumables | ✓ | ✓ | ✓ |
| upstream-bioreactors | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpaepa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | €21.102 billion (fiscal year 2025) | ir-api.eqs.com · reports.emdgroup.com |
| Headcount | 62,461 employees worldwide (as of December 31, 2025) | ir-api.eqs.com · reports.emdgroup.com |
| Production site | Over 55 manufacturing and testing sites worldwide, including facilities in Darmstadt, Germany; Molsheim, France; Danvers, Massachusetts, USA; Wuxi, China; Daejeon, Korea; and Blarney, Ireland. | megaproject.com · storage.mtender.gov.md · businesswire.com · merckmillipore.com · sigmaaldrich.com |
| Capacity | Significant expansion through various multi-year investments including a €150 million filter manufacturing facility in Ireland, a >€300 million bioprocessing center in Korea, a €130 million expansion in Molsheim, and a €25 million/€29 million BioReliance testing facility in Darmstadt. | ir-api.eqs.com · megaproject.com · businesswire.com · reports.emdgroup.com · sigmaaldrich.com |
| Certification | ISO 9001, ISO 14001, ISO 50001, ISO 27001, ISO 45001, ISO 13485, ISO 17025, ISO 17034, FSSC 22000, and Excipact GMP/GDP certifications. | dqsglobal.com · excipact.org · reports.merckgroup.com · sigmaaldrich.com |
| Regulatory approval | Maintains various regional regulatory and quality compliance standards, including US-FDA, EU-GMP, Japan PMDA, UK MHRA, WHO-GMP, and other regional certifications for APIs and pharmaceutical ingredients. medium confidence | chemxpert.com · merckmillipore.com |
Independent sources: businesswire.com · chemxpert.com · dqsglobal.com · excipact.org · ir-api.eqs.com · megaproject.com · merckmillipore.com · reports.emdgroup.com · reports.merckgroup.com · sigmaaldrich.com · storage.mtender.gov.md
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cell culture media (B2B consumable) | cleanroom-facilities | Low | → |
| Media manufacturing (B2B production equipment) | cleanroom-facilities | Low | → |
| Single-use assemblies | consumables | Low | → |
| Single-use bag bioreactors (50L-2000L) | upstream-bioreactors | Low | → |
| Single-use bioprocessing & modular factories | upstream-bioreactors | Low | → |
| Sterility testing systems | analytics-pat | Low | → |
| Water purification & lab water systems | cleanroom-facilities | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.